Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 ,inter alia, to consider and approve Standalone and Consolidated ....
IPCALAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ipca Laboratories has informed the stock exchanges that its Board of Directors will meet on Monday, 11 August 2025 to consider and approve the standalone and consolidated unaudited financial results for the first quarter of FY2025-26 (quarter ended 30 June 2025). The filing is made under SEBI's Listing Obligations and Disclosure Requirements (Regulation 29 read with Regulation 47). It also reiterates that the insider trading window is closed from 1 July 2025 and will remain so until 48 hours after results are declared, i.e., till 13 August 2025. No financial figures, guidance, or business decisions are disclosed in this intimation — it is purely a procedural advance notice ahead of the earnings announcement.
No immediate impact on the stock — this is a routine advance notice. Investors should track the actual Q1 FY26 results announcement on or after 11 August 2025 for revenue, profit, and margin trends that could move the share price.